Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| fruit/legume fibre - [Clostridium] methoxybenzovorans |
👶
A combination of quercetin and resveratrol reduces obesity in high-fat diet-fed rats by modulation of gut microbiota. Food & function (Food Funct ) Vol: 8 Issue 12 Pages: 4644-4656 Pub: 2017 Dec 13 Epub: Authors Zhao L , Zhang Q , Ma W , Tian F , Shen H , Zhou M , Publication Publication |
| fruit/legume fibre - [Clostridium] methoxybenzovorans |
👶
Blueberry and cranberry anthocyanin extracts reduce bodyweight and modulate gut microbiota in C57BL/6Β J mice fed with a high-fat diet. European journal of nutrition (Eur J Nutr ) Vol: Issue Pages: Pub: 2021 Jan 3 Epub: 2021 Jan 3 Authors Liu J , Hao W , He Z , Kwek E , Zhu H , Ma N , Ma KY , Chen ZY , Publication |
| fruit/legume fibre - [Clostridium] methoxybenzovorans |
👶
Resveratrol alleviates DSS-induced IBD in mice by regulating the intestinal microbiota-macrophage-arginine metabolism axis. European journal of medical research (Eur J Med Res ) Vol: 28 Issue 1 Pages: 319 Pub: 2023 Sep 2 Epub: 2023 Sep 2 Authors Xu X , Ocansey DKW , Pei B , Zhang Y , Wang N , Wang Z , Mao F , Publication |
| fruit/legume fibre - [Clostridium] methoxybenzovorans |
👶
Pomegranate juice alters the microbiota in breast milk and infant stool: a pilot study. Food & function (Food Funct ) Vol: 13 Issue 10 Pages: 5680-5689 Pub: 2022 May 23 Epub: 2022 May 23 Authors Henning SM , Yang J , Lee RP , Huang J , Thames G , Korn M , Ben-Nissan D , Heber D , Li Z , Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
